Cargando…
Tissue expression of MMP-9, TIMP-1, RECK, and miR338-3p in prostate gland: can it predict cancer?
Prostate cancer is the most frequent malignancy affecting men worldwide. Due to the low sensitivity and specificity of the prostate-specific antigen test and the digital rectal exam as screening modalities, several alternatives are being studied. This study aimed to evaluate the application of MMP-9...
Autores principales: | de Moraes, Rodolfo Pacheco, Pimenta, Ruan, Mori, Fernando Noboru Cabral, dos Santos, Gabriel Arantes, Viana, Nayara Izabel, Guimarães, Vanessa Ribeiro, de Camargo, Juliana Alves, Leite, Katia Ramos Moreira, Srougi, Miguel, Nahas, William Carlos, Reis, Sabrina T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shiraz University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798274/ https://www.ncbi.nlm.nih.gov/pubmed/35097136 http://dx.doi.org/10.22099/mbrc.2021.40912.1646 |
Ejemplares similares
-
Loss of TIMP-1 immune expression and tumor recurrence in localized prostate cancer
por: dos Reis, Sabrina Thalita, et al.
Publicado: (2015) -
Controlling RECK miR21 Promotes Tumor Cell Invasion and Is Related to Biochemical Recurrence in Prostate Cancer
por: Leite, Katia R. M., et al.
Publicado: (2015) -
miR-618: possible control over TIMP-1 and its expression in localized prostate cancer
por: Ivanovic, Renato F., et al.
Publicado: (2018) -
The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer
por: Camargo, Juliana A., et al.
Publicado: (2023) -
MMP9 overexpression is associated with good surgical outcome in children with UPJO: Preliminary results
por: Reis, Sabrina Thalita, et al.
Publicado: (2016)